In this online, self-learning activity:
Irritable bowel syndrome (IBS) is among the most common disorders seen by primary care as well as gastroenterology specialty clinics. Patients with IBS usually present with chronic abdominal pain and altered bowel habit, in the absence of any other disease to cause these sorts of symptoms. Factors such as genetics, immune function, microbiome, psychological and environmental factors could predispose patients to develop of IBS.
The following healthcare professionals: gastroenterologists and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in gastroenterology; and any other healthcare professionals with an interest in or who clinically encounter patients with IBS-C.
This activity is supported by an educational grant from Synergy.
Release Date: April 30, 2018 -- Expiration Date: April 30, 2020
Faculty: Christopher V. Almario , MD
Introduction content: cursory refresher and review of IBS-C
Treatment of IBS-C
Summary, conclusions, and best practice recap
By the end of the session the participant will be able to:
ACCME Activity #201226539ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Dr. Christopher V. Almario, M.D., Assistant Professor-in-Residence of Medicine at Cedars-Sinai Medical Center, Los Angeles, CA, is a stock holder in Gilead, Madrigal, Google, Disney, and My Total Health and has received research grant support from Takeda, Novartis, and Shire
Disclosures of Educational Planners: Charles Turck, PharmD, BCPS, BCCCP has no relevant conflicts of interest to disclose.
Commercial Support Disclosure: This activity is supported by an educational grant from Synergy.
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.
Short Bowel Syndrome - updates from DDW 2018
Ulcerative Colitis: Updates from the DDW 2019 Annual Meeting
Pediatric Crohn's disease: Therapeutic updates and optimizing treatment
Short bowel syndrome: therapeutic updates and optimizing treatment